Medscape has launched a new education program for providers seeking to enhance their knowledge of gene therapy for haemophilia. “Clinical Advances in Gene Therapy for Haemophilia” is presented through a collaboration between Medscape, the European Haemophilia Consortium, the National Hemophilia Foundation and the World Federation of Hemophilia. The program is supported by an independent educational grant from BioMarin.

Upcoming materials will include important information on the science behind gene therapy for haemophilia, the latest safety and efficacy data from clinical trials and the potential role for gene therapy in addressing the challenges of current treatment methods.

“Test Your Knowledge of Gene Therapy for Hemophilia,” is the first activity to become available in the new series. It is intended for hematologists, pediatricians and other health care professionals who manage patients with haemophilia.

Upon completion, participants will have increased knowledge on:

  • Research on gene therapy in haemophilia
  • New findings from clinical trials on gene therapy in haemophilia

If you are already registered with Medscape, follow this link to “Test Your Knowledge of Gene Therapy for Hemophilia.”

Access this link to visit the “Clinical Advances in Gene Therapy for Hemophilia” homepage. 

If you are not already registered, visit Medscape.org and register free of charge.